Streetbeat News

Analyst Ratings

ARMK

BAC

C

COTY

GS

LVS

MCD

TTD

UNH

WEX

Top Wall Street analysts have updated their price targets for several major companies, including WEX Inc., The Trade Desk, Aramark, McDonald's, Coty, Goldman Sachs, UnitedHealth, Las Vegas Sands, Citigroup, and Bank of America. These changes reflect varying outlooks, with some companies receiving target increases and others decreases.

Portfolio Pulse from Avi Kapoor

October 16, 2024 | 7:24 pm

UHS

Universal Health Services shares rose following an upgrade by TD Cowen from Hold to Buy, with a price target increase from $220 to $283.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 7:20 pm

PNC

Wells Fargo analyst Whit Mayo has maintained an Overweight rating on PNC Financial Services Group and raised the price target from $204 to $215.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 7:19 pm

STT

Wells Fargo analyst Mike Mayo has maintained an Overweight rating on State Street (NYSE:STT) and increased the price target from $98 to $106.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 7:18 pm

PM

Investors are showing significant interest in Philip Morris Intl (NYSE:PM) options, with a mix of bullish and bearish trades. The options activity suggests a price range of $100 to $122. Analysts have mixed ratings, with target prices ranging from $103 to $140.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 7:16 pm

HD

Home Depot has seen unusual options activity with a bullish stance from major investors. Out of 9 trades, 7 were calls totaling $1,576,800, and 2 were puts totaling $123,000. Analysts have mixed ratings, with price targets ranging from $400 to $460. The stock is currently trading at $418.2, up 0.63%, but may be overbought.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 7:16 pm

GOLD

High-rolling investors are showing interest in Barrick Gold (NYSE:GOLD) with significant options activity. The sentiment is mixed, with 40% bullish and 40% bearish. The stock is currently trading at $20.28, with a potential target price of $23.0. An analyst from UBS maintains a Buy rating.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 7:15 pm

QCOM

Citigroup analyst Christopher Danely maintains a Neutral rating on Qualcomm and lowers the price target from $200 to $185.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 7:14 pm

JNJ

Citigroup analyst Joanne Wuensch maintains a Buy rating on Johnson & Johnson and raises the price target from $180 to $185.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 7:11 pm

DECA

SCLX

Scilex Holding Company (NASDAQ:SCLX) is exploring strategic options, including a potential spinoff or dividend distribution. The company is also considering listing its securities outside the U.S. Scilex has three FDA-approved products and a promising Phase 3 candidate, SEMDEXA, which could become a blockbuster treatment for sciatica. Alliance Global Partners initiated coverage with a Buy rating and a $14 price target. Scilex's stock rose 6.5% following the news.

Portfolio Pulse from Vandana Singh

October 16, 2024 | 7:07 pm